The fact that we’re having to still debate these types of details in mid-January 2026 is an indictment of NWBO management because:
A. 5+years from data lock we should have secured regulatory approval somewhere (besides Switzerland).
B. If we didn’t secure approval we could at least be kept better informed about what is going on. Nobody asked NWBO to allegedly pinkie-swear not to update us and it’s not like NWBO has allegedly had any problems changing plans that investors relied upon when it suited them so they can legally update if they want and what’s the MHRA gonna do, punish us and kill more patients by slow walking our application? Oh wait they already have. 150 days my @$$.
Flipper44, I appreciate your feedback. So, I took your reply and asked AI Gemini the following question:
In this MHRA regulatory approval process, if the CHM opinion is positive, will the MHRA send the Sponsor a “Positive Advice” letter to communicate the positive recommendation to the Sponsor?
Market Data 
Markets 
AI
